HTA23 Restrictions and Real-World Evidence Requirements in the Health Technology Assessment of Gene Therapy Medicinal Products in Europe, Canada, Australia, and the United States
| Autor: | Hubscher, E, Wiltshire, L, Young, HHI, Brackley, A, Ko, S |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S300-S300 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect